日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Final 3-year results from the EVIDENS study, an observational study of nivolumab in non-small cell lung cancer

EVIDENS 研究的最终 3 年结果,这是一项关于纳武利尤单抗治疗非小细胞肺癌的观察性研究

Barlesi, Fabrice; Dixmier, Adrien; Debieuvre, Didier; Raspaud, Christophe; Auliac, Jean-Bernard; Benoit, Nicolas; Bombaron, Pierre; Moro-Sibilot, Denis; Asselain, Bernard; Audigier-Valette, Clarisse; Brellier, Florence; Cotté, François-Emery; Khalife, Yaacoub; Pérol, Maurice

Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study

纳武利尤单抗治疗法国肺癌患者的有效性和安全性:来自真实世界 EVIDENS 研究的初步结果

Barlesi, Fabrice; Dixmier, Adrien; Debieuvre, Didier; Raspaud, Christophe; Auliac, Jean-Bernard; Benoit, Nicolas; Bombaron, Pierre; Moro-Sibilot, Denis; Audigier-Valette, Clarisse; Asselain, Bernard; Egenod, Thomas; Rabeau, Audrey; Fayette, Jérôme; Sanchez, Myriam Locatelli; Labourey, Jean-Luc; Westeel, Virginie; Lamoureux, Pauline; Cotte, François-Emery; Allan, Victoria; Daumont, Melinda; Dumanoir, Juliette; Reynaud, Dorothée; Calvet, Christophe Yannick; Ozan, Nicolas; Pérol, Maurice